Member Info for Merchantbanker

Itsallagame - your game is over, final whistle has been blown. You've called this completely wrong, failed to see what is there plain in front of everyone's eyes.

Rayofhope - you lucky bugger, kudos to anyone taking advantage

Took some of the sting out the market there, but wont be able to hold it tomorrow, with or without news.

We have the best Ig self test (soon to be) and the only lateral flow triple test.

A few just under 82 were available NT 82.5 now

Looks like they have shut the shop early!

Going to be one hell of a few weeks. Distribution agreements already in place for Antigen tests too.....??

Looks like the mms not appreciating this at this late hour... NT

"Screen4 Ltd have teamed up with one of the largest diagnostic businesses across the globe – Omega Diagnostics"

https://screen4.org/visitect-covid19-rapid-antibody-test/

They told us in the last RNS that it would be commercialised this month (Sep). I know with aim it's the norm to assume nothing has happened unless you get 5 RNS confirming it, but Omega continue to prove that they do what they say they were going to do.

And on sale in the UK - Not just an export test for low income countries like many assumed!!!

Visitect Triple antibody test on sale £19 a test. £££££

"The only rapid test that identifies all 3 antibodies (IgM, IgA and IgG), increasing the window of detection"

https://screen4.org/product/visitect-rapid-finger-prick-antibody-test/

Okehurst - At the moment I am working on the basis that we are a supplier to the UK RTC at £1.50 a unit for UK Gov sales. Clearly for non gov sales we should expect a higher return. But the set up of the UK RTC is one thing that perhaps needs to be ironed out. Because Abingdon are the lead. In who's name will sales be registered? Do they set up a formal JV? Do the 4 companies look after their own private sales after UK Gov? If the total interest and expected sales is far greater than the government commitment, they may just agree a flat price for all units, say £2, knowing that if they lose on UK gov sales they gain elsewhere. We will just have to wait on the details, and I am sure we will learn more before the MOU expires, but the base assumption of 200k per week @ £1.50 will be highly lucrative, with 800k spare for higher profit Mologic tests. Anything more fruitful than that will be a bonus.

Yes it is a good long term play, but i believe any day there will be a huge RNS that will blow the market away.

Hardly installs confidence.....

"The purchaser shall be responsible for assessing whether the product is suitable for the purpose as the
manufacturer does not guarantee any particular result will be achieved through the use of the product."

Having a go at CK shows exactly how little you know or understand about this. He has turned the company into profitability. The sheer fact they are a part of the UK RTC is testament to how well the business is regarded. And Colin has done a fine job to secure the deal with Mologic, which could be one of the best bits of business the industry has seen. Look at how lean the admin expenses are compared to others. Zero debt. The only thing i would question is whether they are dreaming big enough and if they are perhaps playing it too safe with expansion plans, but i suspect they have bigger plans than they have currently let on, as evidenced ion the recent Q&A. It's a good problem to have seeing as the current planned capacity can drive a valuation in excess of £900m.

It is refreshing with an AIM investment to see a CEO that gets on with the job and delivers rather than spends 90% of his time talking about things that have a 10% chance of happening and desperately trying to prop up a share price. Under promise over deliver might be a cliche, but with CK it will do us very well.

TWatcher - in general i agree.... you can sell crap with good marketing, but it's not a sustainable model.... high quality products sell themselves and demand naturally finds the products rather than creating demand...... especially in this domain

Safy - we know very little about the antigen tests by Mologic. They have been working on them since March/April. CK suggested development could complete by end of Aug/Sep. The first we find out about their products seems to be when they are CE marked, so this could happen any day. Based on Mologic's track record I would back them to deliver a competitive test. They are not rushing out products to capitalise, they are trying to save lives and end a global pandemic. Mologic may not be the best partner to ramp up excitement of the products we have, but in the long run, they deliver, they have proven success and their priorities are in the right place. They have the expertise and the backing. I wouldn't be surprised if the Mologic Antigen tests really explode into something big.

Success is all about the quality of your products. That is the hardest thing to achieve, and ODX have got that spot on. We have top quality products. Where there is a testing shortage, if you have high quality products at very competitive prices, sales will not be a problem. Capacity can be expanded further but it's not an overnight process. The antibody market is a slower moving market than the antigen market, but we have 3 high quality products ready to go. The lateral flow market for Antigen testing could well be the more profitable opportunity and we are right at the head of the market with that too.

Slim pickings on the morning drop today..... going back up, most likely a nice blue day coming.

Absolute garbage there is not a chance of running out of money. The use of the placing is clear to see in the prospectus and the core business breaks even to cover admin expenses. It is only £1.1m out of the money raised to get to £500k capacity.

Anyone with half a brain cell can work out that with the products we have sales will not be a problem when all the i's are dotted and t's crossed. Our capacity will be pushed to the limit.